Further testing on other EGFR mutated lines will be critical to setup the relationship between EGFR mutation and TGFβ1 insensitivity and to understand the mechanism of TGFβ1 sensitivity in NSCLC. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.